BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 2487543)

  • 1. Role of platelet inhibitor therapy in myocardial infarction.
    Stein B; Fuster V
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):797-813. PubMed ID: 2487543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarction.
    Jafri SM; Zarowitz B; Goldstein S; Lesch M
    Prog Cardiovasc Dis; 1993; 36(1):75-83. PubMed ID: 8321905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet antiaggregants in the treatment of arterial thrombosis].
    Ferlito S
    Minerva Cardioangiol; 1991 Oct; 39(10):375-89. PubMed ID: 1803283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Shalaev SV
    Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
    [No Abstract]   [Full Text] [Related]  

  • 6. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
    Hirsh J
    Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet and anticoagulant therapy in acute myocardial infarction.
    Jafri SM
    Henry Ford Hosp Med J; 1991; 39(3-4):195-9. PubMed ID: 1804824
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of myocardial infarction.
    Davies JA
    Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antiplatelet drugs in the prevention of cardiovascular events.
    Tendera M; Wojakowski W
    Thromb Res; 2003 Jun; 110(5-6):355-9. PubMed ID: 14592562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
    Klimt CR; Doub PH; Doub NH
    Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet inhibition in the management of thrombosis.
    Didisheim P; Kazmier FJ; Fuster V
    Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Harker LA
    Circulation; 1986 Feb; 73(2):206-23. PubMed ID: 3510760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of therapeutic interventions in myocardial infarction. Emphasis on secondary prevention.
    Hinstridge V; Speight TM
    Drugs; 1991; 42 Suppl 2():8-20. PubMed ID: 1718703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism.
    Stein B; Fuster V
    Am J Cardiol; 1989 Jul; 64(4):33B-40B. PubMed ID: 2665469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI).
    Tran H; Mehta SR; Eikelboom JW
    Vasc Health Risk Manag; 2006; 2(4):379-87. PubMed ID: 17323592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.